SlideShare a Scribd company logo
1 of 12
ACQUIRED MITRAL
STENOSIS IN THE ADULT
ASE 2 Minute Tutorials: MS
Rheumatic Calcific
Two main etiologies
Leaflet thickening most
pronounced at the tips, giving
the characteristic “hockey-
stick” appearance.
Severe calcification of the mitral annulus,
extending into the leaflets. Typically seen in
the elderly (“senile”).
ASE 2 Minute Tutorials: MS
Commissural fusion.
Rheumatic mitral stenosis, although uncommon, is more frequently the cause of mitral stenosis
that is severe enough to require intervention.
Mitral annular calcification is much more common, though it is less often severe enough to cause
significant stenosis.
Anatomic
- Mitral valve area (MVA) by:
*Planimetry (2D and 3D)
*Continuity
*PISA
Severity assessment
ASE 2 Minute Tutorials: MS
Hemodynamic
- Transmitral gradient (heart rate and flow dependent)
- Pressure half time (PHT)
- Pulmonary artery systolic pressure (PASP)
Classification
- Severe, if MVA is ≤1.5 cm2 ; PHT ≥ 150 ms
- Very severe, if MVA is ≤ 1.0 cm2 ; PHT ≥ 220 ms
2D
MVA by planimetry (2D and 3D)
ASE 2 Minute Tutorials: MS
3D
3D planimetry, whenever feasible, is more
accurate than to 2D planimetry, and is
therefore the preferred methodology.
Principle
The stroke volumes proximal and
distal to the stenotic mitral valve
must be equal.
Mitral inflow = Aortic outflow
MVA by continuity
ASE 2 Minute Tutorials: MS
D= LVOT diameter
VTI = Velocity time integral
D
VTIAortic
VTIMitral
Principle
As flow accelerates towards the narrowed MV
orifice, it forms hemispheric shells of increasing
velocity and decreasing radius.
Because of mitral leaflet doming and the funnel
shaped inflow, an angle correction factor of
â°/180° needs to be accounted for, with â being
the angle between the 2 leaflets at the atrial side.
MVA = 6.28 r2 x Aliasvel/PeakMSvelocity x â°/180°
MVA by PISA
ASE 2 Minute Tutorials: MS
r = PISA radius
Aliasvel = Aliasing velocity
PeakMSvelocity = Peak MS velocity
â° = angle between the 2 leaflets
â°
Principle
The mean pressure gradient varies with heart
rate and forward flow.
However, usually*:
<5 mm Hg – mild MS
5–10 mm Hg – moderate MS
>10 mm Hg – severe MS
*at heart rates between 60-80 bpm and in
sinus rhythm.
Transmitral gradient
ASE 2 Minute Tutorials: MS
Principle
The PHT reflects the time taken for the trans-
mitral pressure gradient to decay to half its
value at the onset of diastole.
There is a linear and inverse relationship
between MVA and PHT: the more severe the
MS, the longer the PHT
Empirical formula to derive MVA from PHT:
MVA = 220/PHT
Pressure Half Time (PHT)
ASE 2 Minute Tutorials: MS
Principle
The obstruction of flow at the mitral orifice
results in pulmonary hypertension.
The degree of pulmonary hypertension is a
measure of the hemodynamic burden of MS.
Elevated pulmonary artery systolic pressure
(PASP) >30 mm Hg is typically seen in severe
MS.
PASP can be estimated by measuring the
tricuspid regurgitant jet maximum velocity by
continuous wave (CW) spectral Doppler.
PASP = 4 (TR VMax)2 + RA pressure
Estimated pulmonary pressure
ASE 2 Minute Tutorials: MS
Principle
Exercise stress testing
ASE 2 Minute Tutorials: MS
Mitral stenosis is considered hemodynamically significant, if during exercise:
- Pulmonary artery wedge pressure is greater than 25 mm Hg or,
- Mean mitral valve gradient is greater than 15 mm Hg.
Mean gradient of 9 mmHg at rest
(HR of 72 bpm)
Exercise
Mean gradient of 19 mmHg with exercise
(HR of 110 bpm)
Intervention
ASE 2 Minute Tutorials: MS
Types Indications
- Mitral Valve Surgery.
- PMBC: Percutaneous mitral
balloon commissurotomy
(typically performed under
TEE guidance).
Nishimura et.al. J Am Coll Cardiol. 2014;63:e57-185
• Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA, O'Gara PT, Ruiz CE,
Skubas NJ, Sorajja P, Sundt TM, 3rd, Thomas JD. 2014 aha/acc guideline for the management of
patients with valvular heart disease: A report of the american college of cardiology/american heart
association task force on practice guidelines. J Am Coll Cardiol. 2014;63:e57-185
https://www.sciencedirect.com/science/article/pii/S0735109714012790?via%3Dihub
• Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka
PA, Quinones M. Echocardiographic assessment of valve stenosis: Eae/ase recommendations for
clinical practice. J Am Soc Echocardiogr. 2009;22:1-23
https://www.asecho.org/wp-content/uploads/2014/05/2009_Echo-Assessment-of-Valve-Stenosis.pdf
References
ASE 2 Minute Tutorials: MS

More Related Content

Similar to 2MT-Mitral-Stenosis-SH-adjustedVR.pptx

Biophysics ofcardiovascularsystem fin
Biophysics ofcardiovascularsystem finBiophysics ofcardiovascularsystem fin
Biophysics ofcardiovascularsystem fin
MUBOSScz
 
Exercise stress ecg. dmo
Exercise stress ecg. dmoExercise stress ecg. dmo
Exercise stress ecg. dmo
Adarsh
 
Pulsecor Presentation
Pulsecor PresentationPulsecor Presentation
Pulsecor Presentation
steven3237
 
Ecg basics & cardicac physiology
Ecg basics & cardicac physiologyEcg basics & cardicac physiology
Ecg basics & cardicac physiology
Subhanjan Das
 

Similar to 2MT-Mitral-Stenosis-SH-adjustedVR.pptx (20)

Challenges in Multivalvular Disease.
Challenges in Multivalvular Disease.Challenges in Multivalvular Disease.
Challenges in Multivalvular Disease.
 
echo pada penyakit jantung katup final.pptx
echo pada penyakit jantung katup final.pptxecho pada penyakit jantung katup final.pptx
echo pada penyakit jantung katup final.pptx
 
Advanced cardiac life support
Advanced cardiac life support  Advanced cardiac life support
Advanced cardiac life support
 
Anesthesia related presentation very helpful
Anesthesia related presentation very helpfulAnesthesia related presentation very helpful
Anesthesia related presentation very helpful
 
Echocardiography in mitral stenosis
Echocardiography in mitral stenosisEchocardiography in mitral stenosis
Echocardiography in mitral stenosis
 
Biophysics ofcardiovascularsystem fin
Biophysics ofcardiovascularsystem finBiophysics ofcardiovascularsystem fin
Biophysics ofcardiovascularsystem fin
 
TMT.ppt
TMT.pptTMT.ppt
TMT.ppt
 
Ojchd.000522
Ojchd.000522Ojchd.000522
Ojchd.000522
 
Ojchd.000522
Ojchd.000522Ojchd.000522
Ojchd.000522
 
Exercise stress ecg. dmo
Exercise stress ecg. dmoExercise stress ecg. dmo
Exercise stress ecg. dmo
 
Myocardial triglyceride Cardiac Amyloidosis MR Spectroscopy
Myocardial triglyceride Cardiac Amyloidosis MR SpectroscopyMyocardial triglyceride Cardiac Amyloidosis MR Spectroscopy
Myocardial triglyceride Cardiac Amyloidosis MR Spectroscopy
 
bpmonitoring.pdf
bpmonitoring.pdfbpmonitoring.pdf
bpmonitoring.pdf
 
Non Invasive and Invasive Blood pressure monitoring RRT
Non Invasive and Invasive Blood pressure monitoring RRTNon Invasive and Invasive Blood pressure monitoring RRT
Non Invasive and Invasive Blood pressure monitoring RRT
 
Mathematical modeling of health care system.ppt
Mathematical modeling of health care system.pptMathematical modeling of health care system.ppt
Mathematical modeling of health care system.ppt
 
Approach to a patient with Heart rate abnormality in ECG
Approach to a patient with Heart rate abnormality in ECG Approach to a patient with Heart rate abnormality in ECG
Approach to a patient with Heart rate abnormality in ECG
 
clinical hemodynamics in Mitral stenosis
clinical hemodynamics in Mitral stenosisclinical hemodynamics in Mitral stenosis
clinical hemodynamics in Mitral stenosis
 
Echocardiography in mitral_stenosis
Echocardiography in mitral_stenosisEchocardiography in mitral_stenosis
Echocardiography in mitral_stenosis
 
Mitral Stenosis with pulsus alternans
Mitral Stenosis with pulsus alternansMitral Stenosis with pulsus alternans
Mitral Stenosis with pulsus alternans
 
Pulsecor Presentation
Pulsecor PresentationPulsecor Presentation
Pulsecor Presentation
 
Ecg basics & cardicac physiology
Ecg basics & cardicac physiologyEcg basics & cardicac physiology
Ecg basics & cardicac physiology
 

Recently uploaded

Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRYDEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
 

2MT-Mitral-Stenosis-SH-adjustedVR.pptx

  • 1. ACQUIRED MITRAL STENOSIS IN THE ADULT ASE 2 Minute Tutorials: MS
  • 2. Rheumatic Calcific Two main etiologies Leaflet thickening most pronounced at the tips, giving the characteristic “hockey- stick” appearance. Severe calcification of the mitral annulus, extending into the leaflets. Typically seen in the elderly (“senile”). ASE 2 Minute Tutorials: MS Commissural fusion. Rheumatic mitral stenosis, although uncommon, is more frequently the cause of mitral stenosis that is severe enough to require intervention. Mitral annular calcification is much more common, though it is less often severe enough to cause significant stenosis.
  • 3. Anatomic - Mitral valve area (MVA) by: *Planimetry (2D and 3D) *Continuity *PISA Severity assessment ASE 2 Minute Tutorials: MS Hemodynamic - Transmitral gradient (heart rate and flow dependent) - Pressure half time (PHT) - Pulmonary artery systolic pressure (PASP) Classification - Severe, if MVA is ≤1.5 cm2 ; PHT ≥ 150 ms - Very severe, if MVA is ≤ 1.0 cm2 ; PHT ≥ 220 ms
  • 4. 2D MVA by planimetry (2D and 3D) ASE 2 Minute Tutorials: MS 3D 3D planimetry, whenever feasible, is more accurate than to 2D planimetry, and is therefore the preferred methodology.
  • 5. Principle The stroke volumes proximal and distal to the stenotic mitral valve must be equal. Mitral inflow = Aortic outflow MVA by continuity ASE 2 Minute Tutorials: MS D= LVOT diameter VTI = Velocity time integral D VTIAortic VTIMitral
  • 6. Principle As flow accelerates towards the narrowed MV orifice, it forms hemispheric shells of increasing velocity and decreasing radius. Because of mitral leaflet doming and the funnel shaped inflow, an angle correction factor of â°/180° needs to be accounted for, with â being the angle between the 2 leaflets at the atrial side. MVA = 6.28 r2 x Aliasvel/PeakMSvelocity x â°/180° MVA by PISA ASE 2 Minute Tutorials: MS r = PISA radius Aliasvel = Aliasing velocity PeakMSvelocity = Peak MS velocity â° = angle between the 2 leaflets â°
  • 7. Principle The mean pressure gradient varies with heart rate and forward flow. However, usually*: <5 mm Hg – mild MS 5–10 mm Hg – moderate MS >10 mm Hg – severe MS *at heart rates between 60-80 bpm and in sinus rhythm. Transmitral gradient ASE 2 Minute Tutorials: MS
  • 8. Principle The PHT reflects the time taken for the trans- mitral pressure gradient to decay to half its value at the onset of diastole. There is a linear and inverse relationship between MVA and PHT: the more severe the MS, the longer the PHT Empirical formula to derive MVA from PHT: MVA = 220/PHT Pressure Half Time (PHT) ASE 2 Minute Tutorials: MS
  • 9. Principle The obstruction of flow at the mitral orifice results in pulmonary hypertension. The degree of pulmonary hypertension is a measure of the hemodynamic burden of MS. Elevated pulmonary artery systolic pressure (PASP) >30 mm Hg is typically seen in severe MS. PASP can be estimated by measuring the tricuspid regurgitant jet maximum velocity by continuous wave (CW) spectral Doppler. PASP = 4 (TR VMax)2 + RA pressure Estimated pulmonary pressure ASE 2 Minute Tutorials: MS
  • 10. Principle Exercise stress testing ASE 2 Minute Tutorials: MS Mitral stenosis is considered hemodynamically significant, if during exercise: - Pulmonary artery wedge pressure is greater than 25 mm Hg or, - Mean mitral valve gradient is greater than 15 mm Hg. Mean gradient of 9 mmHg at rest (HR of 72 bpm) Exercise Mean gradient of 19 mmHg with exercise (HR of 110 bpm)
  • 11. Intervention ASE 2 Minute Tutorials: MS Types Indications - Mitral Valve Surgery. - PMBC: Percutaneous mitral balloon commissurotomy (typically performed under TEE guidance). Nishimura et.al. J Am Coll Cardiol. 2014;63:e57-185
  • 12. • Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, 3rd, Thomas JD. 2014 aha/acc guideline for the management of patients with valvular heart disease: A report of the american college of cardiology/american heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63:e57-185 https://www.sciencedirect.com/science/article/pii/S0735109714012790?via%3Dihub • Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M. Echocardiographic assessment of valve stenosis: Eae/ase recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1-23 https://www.asecho.org/wp-content/uploads/2014/05/2009_Echo-Assessment-of-Valve-Stenosis.pdf References ASE 2 Minute Tutorials: MS

Editor's Notes

  1. Quantification of MS almost always can be performed with TTE. However TEE mitral valve area by 3D planimetry typically provides superior image quality.